Genocea Biosciences, Inc.
GNCADelisted Jun 2, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001457612
Genocea Biosciences, Inc. was delisted on Jun 2, 2022; its insiders filed their last Form 4 on Jun 3, 2022; 40 institutions reported holding it in 13F filings for Q1 2022, worth $42.1M in total; no superinvestor held it.
Superinvestors holding GNCA, Q1 2022
No superinvestor reported holding GNCA in Q1 2022.